Skip to main content
. 2021 Mar 26;16:807–815. doi: 10.2147/COPD.S294217

Table 4.

Exacerbations and Lung Function During Follow-Up According to Treatment

Patients without ICS During Follow-Up (n = 34) Patients Resuming ICS During Follow-Up (n = 51) p-value
No. of patients with exacerbations (%) 15 (44.1%) 34 (68%) 0.09
ΔFEV1 0.04 L −0.07 L 0.55

Abbreviations: ICS, inhaled corticosteroids; n, numbers; no., numbers; FEV1, forced expiratory volume in 1st second.